Forbes Financial Planning’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Sell
341
-300
-47% -$103K 0.12% 35
2026
Q1
$226K Hold
641
0.13% 36
2025
Q4
$210K Buy
+641
New +$203K 0.12% 35
2024
Q4
Sell
-641
Closed -$207K 32
2024
Q3
$207K Hold
641
0.15% 30
2024
Q2
$200K Buy
+641
New +$188K 0.16% 30

Other funds holding AMGN

Forbes Financial Planning's AMGN Position: Q2 2026 in Review

Forbes Financial Planning reduced its Amgen (AMGN) stake by 47% in Q2 2026, selling an estimated $103K and leaving 341 shares worth $232K. The position accounts for 0.12% of the portfolio, ranked #35.

Forbes Financial Planning first reported a position in AMGN in Q2 2024 and has held it in 5 quarters since. 2,083 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Forbes Financial Planning held 341 shares of Amgen worth $232K as of Q2 2026.
  • Forbes Financial Planning sold 300 Amgen shares in Q2 2026, an estimated $103K.
  • Amgen made up 0.12% of Forbes Financial Planning's portfolio in Q2 2026, its #35 holding.
  • Forbes Financial Planning first reported a position in Amgen in Q2 2024 and has held it in 5 quarters since.
  • 2,083 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Forbes Financial Planning's 13F filing for Q2 2026, filed 23 Jul 2026.